Grünenthal GmbH - Company & Market Research Reports

Grünenthal GmbH is a research-based pharmaceutical company that researches, develops, and produces pain treatment products. Its product portfolio includes a range of medicinal products for chronic and acute pain. The company offers its products for the relief of nociceptive pain, as well as neuropathic pain. It serves customers in Germany and internationally. The company was founded in 1946 and is based in Aachen, Germany.


Germany Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles - Product Thumbnail Image

Germany Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles

  • Report
  • 200 Pages
From
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays  - Detailed Analysis On Technologies And Pipeline Development - Product Thumbnail Image

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development

  • Report
  • 70 Pages
From
Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts - Product Thumbnail Image

Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts

  • Report
  • 283 Pages
From
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H2 2016 - Product Thumbnail Image

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H2 2016

  • Report
  • 56 Pages
From
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016 - Product Thumbnail Image

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016

  • Report
  • 51 Pages
From
Neuropathic Pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Neuropathic Pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 618 Pages
From
Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 122 Pages
From
Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 104 Pages
From
Diabetic Neuropathic Pain - Pipeline Review, H2 2016 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Review, H2 2016

  • Report
  • 95 Pages
From
Cancer Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Cancer Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 274 Pages
From
Cancer Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Cancer Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 268 Pages
From
A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market - Product Thumbnail Image

A Product and Pipeline Analysis of the Opioid Therapeutics and Drug Delivery Market

  • Report
  • 75 Pages
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • 767 Pages
From
Musculoskeletal Pain Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Musculoskeletal Pain Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 1007 Pages
From
Low Back Pain Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Low Back Pain Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 334 Pages
From
Chronic Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 95 Pages
From
Chronic Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 489 Pages
From
Acute Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Acute Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 343 Pages
From
Back Pain Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Back Pain Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 369 Pages
From
Post-Operative Pain Global Clinical Trials Review, H1, 2016 - Product Thumbnail Image

Post-Operative Pain Global Clinical Trials Review, H1, 2016

  • Clinical Trials
  • 1697 Pages
From
Loading Indicator
adroll